{
  "id": 14868037,
  "title": "Oklo CPO Alexandra Renner sells $21,156 in shares on Oct 14",
  "url": "https://urgent.news/2026/10/16/oklo-cpo-alexandra-renner-sells-21-156-in-shares-on-oct-14",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-16T04:16:13.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/oklo-cpo-alexandra-renner-sells-21156-in-shares-on-oct-14-93CH-4953066"
  },
  "original_language": "en",
  "account": "Oklo Inc. Chief Product Officer Alexandra Renner sold 688 shares of the company's Class A Common Stock on October 14, 2026, for a total of $21,156. The shares were sold at $30.75 each to fulfill tax withholding obligations related to the vesting and settlement of restricted stock units. The transaction was not a discretionary sale; it was necessary to satisfy tax requirements. This move occurred as Oklo's stock price fell approximately 13.5% over the previous week, although analysts believe the company is still undervalued at its current price, trading below its Fair Value. The company's market capitalization stands at $5.58 billion. Renner's sale came after she acquired 1,521 shares of Oklo Inc. Class A Common Stock on the preceding day, as part of the vesting process for RSUs granted on April 13, 2026. These RSUs granted the right to receive one share of the company's Class A Common Stock, with the vesting occurring in quarterly installments. Post these transactions, Renner personally owns 478,428 shares of Oklo Inc. Class A Common Stock, with an additional 116,390 shares held jointly with a spouse. Oklo Inc. is also planning a new at-the-market stock offering, potentially raising up to $1 billion via the sale of Class A common stock, involving ten sales agents such as Goldman Sachs and Citigroup. UBS updated its estimates, raising 2033-35 adjusted EBITDA projections by 2% due to anticipated expense changes, while maintaining a Neutral rating and lowering the price target to $41. Canaccord Genuity reiterated a Buy rating with a $100 price target, highlighting potential in Oklo's isotope division as Groves-2 progresses. Piper Sandler kept an Overweight rating with a $55 price target, expressing confidence in Oklo's nuclear project timeline following a site visit. Truist Securities maintained a Hold rating with a $51 price target after meeting with Oklo's CFO, noting ongoing development in the company's Power, Fuel, and Isotopes segments. These developments illustrate a variety of analyst sentiments on Oklo's financial outlook and strategic plans. This report was produced with AI assistance and reviewed by an editor.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}